RecruitingNot ApplicableNCT01035112
Magnetic Resonance Imaging of Breast Cancer
Sponsor
Stanford University
Enrollment
500 participants
Start Date
Apr 1, 1995
Study Type
INTERVENTIONAL
Conditions
Summary
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Eligibility
Sex: FEMALEMin Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This study uses MRI scans to get a better look at breast tissue in women who have a suspicious breast lump or abnormality detected by physical exam or mammogram.
**You may be eligible if...**
- You are a woman
- You have had a breast physical exam and a mammogram in the last 3 months
- You have a suspicious breast lump found by exam or mammogram
- You have had a previous lumpectomy for breast cancer and now have a new suspicious area on mammogram
**You may NOT be eligible if...**
- You are male
- You have a pacemaker, metal implants, or aneurysm clips in your body
- You have severe claustrophobia (fear of enclosed spaces)
- You are pregnant or currently breastfeeding
- You had an MRI with contrast dye in the last 48 hours, or iodine contrast in the last 6 hours
- You have a known allergy to MRI contrast dye
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREMRI
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01035112
Related Trials
Genomic Services Research Program
NCT025959571 location
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
NCT052833304 locations
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NCT068852031 location
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT06103864316 locations